| What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia? CU Correll, JM Rubio, JM Kane World Psychiatry 17 (2), 149-160, 2018 | 271 | 2018 |
| Risk factors for anxiety disorders: common and specific effects in a national sample C Blanco, J Rubio, M Wall, S Wang, CJ Jiu, KS Kendler Depression and anxiety 31 (9), 756-764, 2014 | 213 | 2014 |
| Efficacy of 42 pharmacologic cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence CU Correll, JM Rubio, G Inczedy-Farkas, ML Birnbaum, JM Kane, ... JAMA psychiatry 74 (7), 675-684, 2017 | 204 | 2017 |
| Epidemiology of chronic and nonchronic major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions JM Rubio, JC Markowitz, A Alegría, G Pérez‐Fuentes, SM Liu, KH Lin, ... Depression and anxiety 28 (8), 622-631, 2011 | 135 | 2011 |
| Correlates of intimate partner violence perpetration: Results from a national epidemiologic survey M Okuda, M Olfson, S Wang, JM Rubio, Y Xu, C Blanco Journal of traumatic stress 28 (1), 49-56, 2015 | 124 | 2015 |
| Examining the course of hallucinatory experiences in children and adolescents: a systematic review JM Rubio, J Sanjuán, L Flórez-Salamanca, MJ Cuesta Schizophrenia research 138 (2-3), 248-254, 2012 | 102 | 2012 |
| Original research quality of life following remission of mental disorders: findings from the national epidemiologic survey on JM Rubio, M Olfson, L Villegas, G Pérez-Fuentes, S Wang, C Blanco J Clin Psychiatry 74 (5), e445-e450, 2013 | 94 | 2013 |
| Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis JM Rubio, G Schoretsanitis, M John, J Tiihonen, H Taipale, D Guinart, ... The Lancet Psychiatry 7 (9), 749-761, 2020 | 82 | 2020 |
| Candidate biomarkers in psychiatric disorders: state of the field A Abi‐Dargham, SJ Moeller, F Ali, C DeLorenzo, K Domschke, G Horga, ... World Psychiatry 22 (2), 236-262, 2023 | 59 | 2023 |
| Persistence of chronic major depression: a national prospective study M Garcia-Toro, JM Rubio, M Gili, M Roca, CJ Jin, SM Liu, C Bastianoni, ... Journal of affective disorders 151 (1), 306-312, 2013 | 57 | 2013 |
| Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times … M Solmi, A Estradé, T Thompson, A Agorastos, J Radua, S Cortese, ... Journal of affective disorders 299, 367-376, 2022 | 54 | 2022 |
| The latent structure and comorbidity patterns of generalized anxiety disorder and major depressive disorder: a national study C Blanco, JM Rubio, M Wall, R Secades‐Villa, K Beesdo‐Baum, S Wang Depression and anxiety 31 (3), 214-222, 2014 | 52 | 2014 |
| Effect of first episode axis I disorders on quality of life JM Rubio, M Olfson, G Pérez-Fuentes, M Garcia-Toro, S Wang, C Blanco The Journal of nervous and mental disease 202 (4), 271-274, 2014 | 44 | 2014 |
| Long-term continuity of antipsychotic treatment for schizophrenia: a nationwide study JM Rubio, H Taipale, A Tanskanen, CU Correll, JM Kane, J Tiihonen Schizophrenia Bulletin 47 (6), 1611-1620, 2021 | 43 | 2021 |
| Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence M Solmi, G Croatto, G Piva, S Rosson, P Fusar-Poli, JM Rubio, ... Molecular Psychiatry 28 (1), 354-368, 2023 | 37 | 2023 |
| Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study JM Rubio, H Taipale, CU Correll, A Tanskanen, JM Kane, J Tiihonen Psychological Medicine 50 (8), 1356-1367, 2020 | 35 | 2020 |
| Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia R Emsley, L Asmal, JM Rubio, CU Correll, JM Kane Schizophrenia Research 225, 55-62, 2020 | 34 | 2020 |
| How and when to use clozapine JM Rubio, JM Kane Acta Psychiatrica Scandinavica 141 (3), 178-189, 2020 | 34 | 2020 |
| The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting … M Solmi, A Estradé, T Thompson, A Agorastos, J Radua, S Cortese, ... Journal of affective disorders 299, 393-407, 2022 | 32 | 2022 |
| A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome D Guinart, F Misawa, JM Rubio, J Pereira, R de Filippis, C Gastaldon, ... Acta Psychiatrica Scandinavica 144 (4), 329-341, 2021 | 32 | 2021 |
